| ‘Real-world’health care priority setting using explicit decision criteria: a systematic review of the literature I Cromwell, SJ Peacock, C Mitton BMC health services research 15, 1-11, 2015 | 98 | 2015 |
| A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer JA Davidson, I Cromwell, SL Ellard, C Lohrisch, KA Gelmon, T Shenkier, ... European Journal of Cancer 49 (11), 2469-2475, 2013 | 58 | 2013 |
| Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada S Cressman, S Lam, MC Tammemagi, WK Evans, NB Leighl, DA Regier, ... Journal of thoracic oncology 9 (10), 1449-1458, 2014 | 51 | 2014 |
| Erlotinib or docetaxel for second-line treatment of non-small cell lung cancer: a real-world cost-effectiveness analysis I Cromwell, K van der Hoek, B Melosky, S Peacock Journal of Thoracic Oncology 6 (12), 2097-2103, 2011 | 38 | 2011 |
| Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: a real-world cost-effectiveness analysis I Cromwell, K van der Hoek, SCM Taylor, B Melosky, S Peacock Lung Cancer 76 (3), 472-477, 2012 | 34 | 2012 |
| Cost-effectiveness analysis of using loss of heterozygosity to manage premalignant oral dysplasia in British Columbia, Canada I Cromwell, DA Regier, SJ Peacock, CF Poh The Oncologist 21 (9), 1099-1106, 2016 | 15 | 2016 |
| Cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in British Columbia, Canada I Cromwell, M Gaudet, SJ Peacock, C Aquino-Parsons BMC Health Services Research 16, 1-10, 2016 | 12 | 2016 |
| A time-and-motion approach to micro-costing of high-throughput genomic assays S Costa, DA Regier, B Meissner, I Cromwell, S Ben-Neriah, E Chavez, ... Current Oncology 23 (5), 304-313, 2016 | 12 | 2016 |
| Health-care practitioners’ preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment S Jiang, AH Anis, I Cromwell, T Mohammadi, KA Schrader, J Lucas, ... Genetics in Medicine 22 (12), 2011-2019, 2020 | 11 | 2020 |
| Pan-Canadian Early Detection of Lung Cancer Study Team. Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada S Cressman, S Lam, MC Tammemagi, WK Evans, NB Leighl, DA Regier, ... J Thorac Oncol 9 (10), 1449-58, 2014 | 11 | 2014 |
| Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis I Cromwell, Z Ferreira, L Smith, K Van der Hoek, G Ogilvie, A Coldman, ... Current Oncology 23 (s1), 14-22, 2016 | 10 | 2016 |
| Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial I Cromwell, LW Smith, K van Der Hoek, L Hedden, AJ Coldman, D Cook, ... Cancer Medicine 10 (9), 2996-3003, 2021 | 8 | 2021 |
| Development and application of a whole disease model of oral cancer to inform health technology management I Cromwell University of British Columbia, 2019 | 3 | 2019 |
| A prospective clinical utility study of the impact of the 21-gene recurrence score assay (Onco type DX) in estrogen receptor positive (ER+) node negative (pN0) breast cancer in … JA Davidson, I Cromwell, S Ellard, CA Lohrisch, KA Gelmon, TN Shenkier, ... Journal of Clinical Oncology 30 (15_suppl), 549-549, 2012 | 3 | 2012 |
| Economic evaluation of rare diseases and the diagnostic odyssey DA Regier, D Weymann, I Cromwell, M Ehman, S Pollard Economic Evaluation in Genomic and Precision Medicine, 47-70, 2023 | | 2023 |
| Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60 DA Regier, B Chan, S Costa, DW Scott, C Steidl, JM Connors, A Karsan, ... Cancers 14 (4), 908, 2022 | | 2022 |
| A Cost-Effective Strategy to Triage Patients with Oral Premalignant Lesions YK LIU, I CROMWELL, A KARSAN, CF POH Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 120 (3), e141, 2015 | | 2015 |
| The Economic Consequences of Delay in Radiotherapy: An Example in Early Breast Cancer I Cromwell | | 2015 |
| COST-EFFECTIVENESS ANALYSIS OF ANAL CANCER SCREENING IN WOMEN WITH CIN II OR CIN III M Gaudet, I Cromwell, S Peacock, C Aquino-Parsons INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 24 (9), 942-942, 2014 | | 2014 |
| Cost & Resource Utilization of Cervical Cancer in British Columbia ZJ Ferreira, I Cromwell, L Smith, S Peacock Value in Health 17 (3), A79-A80, 2014 | | 2014 |
